Literature DB >> 9702172

Salicylate intake and cardiovascular disease: Ingster and Feinleib respond to Hu and Willett.

L M Ingster, M Feinleib.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9702172      PMCID： PMC1508289          DOI： 10.2105/ajph.88.8.1268-a

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  6 in total

Review 1.  Could salicylates in food have contributed to the decline in cardiovascular disease mortality? A new hypothesis.

Authors:  L M Ingster; M Feinleib
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

2.  Urinary salicylate excretion in subjects eating a variety of diets shows that amounts of bioavailable salicylates in foods are low.

Authors:  P L Janssen; P C Hollman; E Reichman; D P Venema; W A van Staveren; M B Katan
Journal:  Am J Clin Nutr       Date:  1996-11       Impact factor: 7.045

Review 3.  Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.

Authors:  V Fuster; M L Dyken; P S Vokonas; C Hennekens
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

Review 4.  Aspirin, platelets, and thrombosis: theory and practice.

Authors:  G J Roth; D C Calverley
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

5.  Aspirin-like effects of selected food additives and industrial sensitizing agents.

Authors:  W R Williams; A Pawlowicz; B H Davies
Journal:  Clin Exp Allergy       Date:  1989-09       Impact factor: 5.018

6.  Salicylates in foods.

Authors:  A R Swain; S P Dutton; A S Truswell
Journal:  J Am Diet Assoc       Date:  1985-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.